Does Biologic Treatment in Psoriasis Reduce the Risk of PsA? Retrospective claims analysis shows that psoriasis patien

Tweet Author

Tweet Content

Does Biologic Treatment in Psoriasis Reduce the Risk of PsA? Retrospective claims analysis shows that psoriasis patients treated with an IL-12/23 inhibitor or an IL-23 inhibitor had a lower risk of developing incident PsA. https://t.co/j73V7zMnkn https://t.co/EhGUXDNNlS

Links

https://bit.ly/3ZwAW6m

My Bum Knee QD Clinic - Lessons from the clinic, brought to you by RhuemNow Live, March 18 &19, 2023 - Dallas, TX

Tweet Author

RheumNow

Tweet Content

My Bum Knee QD Clinic - Lessons from the clinic, brought to you by RhuemNow Live, March 18 &19, 2023 - Dallas, TX https://t.co/nqBiAZsYGY https://t.co/MxhCbrWm3p

Links

https://bit.ly/3JmDazK

BRIDGE-PMR a proof-of-concept trial studied 1 dose of IV RTX in 47 PMR pts - at 1 yr, 52% RTX were in GC-free remission

Tweet Author

RheumNow

Tweet Content

BRIDGE-PMR a proof-of-concept trial studied 1 dose of IV RTX in 47 PMR pts - at 1 yr, 52% RTX were in GC-free remission (compared to 21% given PBO). Eight (33%) patients in the placebo group and six (26%) in the rituximab group had adverse events https://t.co/yv8ezFN5BJ https://t.co/7FOOPbEIf3

Links

https://bit.ly/3JmDHkQ

This poster reports key efficacy outcomes such as ASAS40 response at Week 16 and Week 52 for the overall population and in TNFi-naïve and TNFi-experienced patients. The poster also discusses patients treated with BKZ achieving low disease activity (LDA) based on the ASDAS scores, objective signs of inflammation. An overview of safety and patient disposition to Week 52 will also be given.

Presentation

Marina Magrey Discusses the Poster

Author(s):

Xenofon Baraliakos, Atul Deodhar, Désirée van der Heijde, Marina Magrey, Walter P.Maksymowych, Tetsuya Tomita, Huji Xu, Marga Oortgiesen, Ute Massow, Carmen Fleurinck, Alicia M. Ellis, Tom Vaux, Julie Shepherd‐Smith, Alexander Marten, Lianne S. Gensler

Abstract or description:

This poster reports key efficacy outcomes such as ASAS40 response at Week 16 and Week 52 for the overall population and in TNFi-naïve and TNFi-experienced patients. The poster also discusses patients treated with BKZ achieving low disease activity (LDA) based on the ASDAS scores, objective signs of inflammation. An overview of safety and patient disposition to Week 52 will also be given.

Real-world switching patterns among patients with PsA receiving first-line advanced therapy

Real-world effectiveness in PsA after first-line TNFi: JAKi, IL-17i, or another TNFi

Long-term safety of a JAKi across ~17,000 patient-years

Real-world outcomes in patients with RA remaining on first-line TNFi

Bullous pemphigoid is an autoimmune blistering Dz that may be seen with other hematologic dz - hemophilia A, hypereosino

Tweet Author

RheumNow

Tweet Content

Bullous pemphigoid is an autoimmune blistering Dz that may be seen with other hematologic dz - hemophilia A, hypereosinophilic syndrome, autoimmune thrombocytopenia, aplastic anemia, Heme malignancy (MDS, CLL, etc) https://t.co/i8WdA28hYP https://t.co/RsJMt9RTNl

Links

https://bit.ly/3Jo7RUU

QD Clinic - Abdominal Pain, Arthralgias, and a Poor Diet

8 March 2023

Higher Rehospitalization Rates in Younger SLE Patients

A Medicare study shows that young adults with systemic lupus erythematosus (SLE) exhibit very high 30-day rehospitalization rates (36%) that are significantly higher than older SLE patients and age matched non-SLE patients.

This study was drawn from a 20% national Medicare sample from 2014. Hospitalizations, rehospitalization risk and mortality within 30 days of discharge were calculated for young (aged 18-35 yrs), middle-aged (aged 36-64 yrs), and older (aged 65+ yrs) SLE and non-SLE patients.

8 March 2023

Does Methotrexate Work in Alopecia Universalis?

Alopecia areata totalis (AT) and universalis (AU) are the most severe and difficult to treat forms of alopecia areata (AA). Yet a randomized controlled trial has shows that the combination of methotrexate (MTX) and low-dose prednisone can yield complete hair regrowth in nearly one-third of patients.

Renal Involvement is Pivotal in ANCA-Associated Vasculitis Researchers have identified four different trajectories of

Tweet Author

RheumNow

Tweet Content

Renal Involvement is Pivotal in ANCA-Associated Vasculitis Researchers have identified four different trajectories of kidney function over time in AAV patients, with implications for personalized treatment, as well as future research. https://t.co/O8EaW2MaBx https://t.co/VApYiH66yn

Links

https://bit.ly/3ZuTDHr

ENT involvement studied in 320 ANCA associated vasculitis pts: 65% had ENT involvement w/ median age =52 yrs, & medi

Tweet Author

RheumNow

Tweet Content

ENT involvement studied in 320 ANCA associated vasculitis pts: 65% had ENT involvement w/ median age =52 yrs, & median BVAS3 = 12. Relapse seen in 29% despite immunosupp Rx. No diff in outcomes betw pts Rx w/ oral or IV CTX or RTX https://t.co/MwZSnVVd32 https://t.co/YbrHxnqDw9

Links

https://bit.ly/3YtLTUP

Topics

Does Biologic Treatment in Psoriasis Reduce the Risk of PsA? Retrospective claims analysis shows that psoriasis patien

My Bum Knee QD Clinic - Lessons from the clinic, brought to you by RhuemNow Live, March 18 &19, 2023 - Dallas, TX

BRIDGE-PMR a proof-of-concept trial studied 1 dose of IV RTX in 47 PMR pts - at 1 yr, 52% RTX were in GC-free remission

Real-world switching patterns among patients with PsA receiving first-line advanced therapy

Real-world effectiveness in PsA after first-line TNFi: JAKi, IL-17i, or another TNFi

Long-term safety of a JAKi across ~17,000 patient-years

Real-world outcomes in patients with RA remaining on first-line TNFi

Bullous pemphigoid is an autoimmune blistering Dz that may be seen with other hematologic dz - hemophilia A, hypereosino

QD Clinic - Abdominal Pain, Arthralgias, and a Poor Diet

Renal Involvement is Pivotal in ANCA-Associated Vasculitis Researchers have identified four different trajectories of

ENT involvement studied in 320 ANCA associated vasculitis pts: 65% had ENT involvement w/ median age =52 yrs, & medi

Do you get our email newsletter?

Does Biologic Treatment in Psoriasis Reduce the Risk of PsA? Retrospective claims analysis shows that psoriasis patien

My Bum Knee QD Clinic - Lessons from the clinic, brought to you by RhuemNow Live, March 18 &amp;19, 2023 - Dallas, TX

BRIDGE-PMR a proof-of-concept trial studied 1 dose of IV RTX in 47 PMR pts - at 1 yr, 52% RTX were in GC-free remission

Real-world switching patterns among patients with PsA receiving first-line advanced therapy

Real-world effectiveness in PsA after first-line TNFi: JAKi, IL-17i, or another TNFi

Long-term safety of a JAKi across ~17,000 patient-years

Real-world outcomes in patients with RA remaining on first-line TNFi

Bullous pemphigoid is an autoimmune blistering Dz that may be seen with other hematologic dz - hemophilia A, hypereosino

QD Clinic - Abdominal Pain, Arthralgias, and a Poor Diet

Renal Involvement is Pivotal in ANCA-Associated Vasculitis Researchers have identified four different trajectories of

ENT involvement studied in 320 ANCA associated vasculitis pts: 65% had ENT involvement w/ median age =52 yrs, &amp; medi

My Bum Knee QD Clinic - Lessons from the clinic, brought to you by RhuemNow Live, March 18 &19, 2023 - Dallas, TX

ENT involvement studied in 320 ANCA associated vasculitis pts: 65% had ENT involvement w/ median age =52 yrs, & medi